Outcomes and Cosmesis With Whole Breast Irradiation and Boost

Part of paid clinical trials in Madison, Wisconsin.

Sponsor
University of Wisconsin, Madison
Study ID
NCT06295744
Status
Recruiting
Apply to this trial

Conditions

  • Early-stage Breast Cancer

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Radiation Therapy — RADIATION
    WBI with SIB delivered over 5 fractions

Study Details

This study is being done to evaluate cosmetic, patient-reported outcome measures (PROMs), and toxicities for women undergoing ultra-short whole breast irradiation (WBI) therapy with simultaneous integrated boost (SIB). 50 participants will be on study for up to 60 months.

Key Dates

Start date
Apr 17, 2024
Status verified
Jun 2026
Primary completion
Feb 28, 2029
Completion
Feb 29, 2032

Study Design

Enrollment
50 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: WBI with SIB

Primary Outcome Measure

Harvard Breast Cosmesis Scale Score [ Time Frame: up to 2 years post-treatment (treatment ends up to 5 weeks on study) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UW Carbone Cancer CenterMadisonWisconsin53792-

Find similar trials in Madison, WI

By research site
UW Carbone Cancer Center· Madison, WI

Related Studies